No insider purchase over the last 90 days. The latest, by Raymond, was filed 01 Dec 2025.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 45 declarations
PT Chandra Asri Pacific Tbk, an Indonesian chemicals company with a market capitalisation of IDR 97.3 trillion, has a short record of 45 filings, for trades from May 6, 2024 to November 28, 2025, from only 5 filers. It contains only open-market trades: 30 purchases worth EUR 474,339 (median EUR 12,346) and 15 sales worth EUR 9.7 million (median EUR 418,062), or 67% purchases.
All the sales come from Prajogo Pangestu, listed as Pemegang Saham (shareholder at 5% or more), who signs 15 filings. The largest: EUR 2,180,475 on March 3, 2025, EUR 1,872,845 on March 5, 2025 and EUR 1,243,307 on March 4, 2025.
The purchases come from management (Direksi). Andre Khor Kah Hin signs 14, all purchases, and Raymond 11. Raymond bought EUR 37,517 and EUR 37,386 on November 28, 2025, and Erwin Ciputra EUR 31,384 on March 19, 2025. From March 19 to March 20, 2025, three filers bought EUR 174,958.
2025 has 33 filings, 2024 has 12. Filings appear a median of 2 days after the trade. Over the last twelve months: 2 filings, 2 purchases. For the 30 purchases with a 90-day result: a median of 3.2%, with 50% of results positive, recorded past results, not a forecast.
Headquarters: Indonesia · Founded: 1984 · 1,840 employees (2017) · Wikipedia article
Source: Wikidata (CC0).